UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 233

Sortiert nach

EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells

Oncogene, 2020-03, Vol.39 (13), p.2643-2657

2020

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

Frontiers in oncology, 2024-04, Vol.14, p.1377858-1377858

2024

Link zum Volltext

Verfügbarkeit prüfen

Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

Frontiers in oncology, 2023-05, Vol.13, p.1206768-1206768

2023

Link zum Volltext

Verfügbarkeit prüfen

n-3 Polyunsaturated Fatty Acids and Metabolic Syndrome Risk: A Meta-Analysis

Nutrients, 2017-07, Vol.9 (7), p.703

2017

Link zum Volltext

Verfügbarkeit prüfen

Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication

Investigational new drugs, 2022-02, Vol.40 (1), p.209-214

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of n-3 fatty acid supplements on glycemic traits in Chinese type 2 diabetic patients: A double-blind randomized controlled trial

Molecular nutrition & food research, 2016-10, Vol.60 (10), p.2176-2184

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for bilateral multiple ground glass opacities: An exploratory study for synchronous multiple primary lung cancer

Frontiers in immunology, 2022-10, Vol.13, p.1009621-1009621

2022

Link zum Volltext

Verfügbarkeit prüfen

Supercapacitor‐based coordinated synthetic inertia scheme for voltage source converter‐based HVDC integrated offshore wind farm

Energy systems integration, 2024-03, Vol.6 (1), p.5-17

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China

Frontiers in oncology, 2020-06, Vol.10, p.800-800

2020

Link zum Volltext

Verfügbarkeit prüfen

Improving the Lung Cancer Clinical Trial Development by Incorporating Competing Risk Factors

BioMed research international, 2021, Vol.2021, p.2477285-8

2021

Link zum Volltext

Verfügbarkeit prüfen

Intraday variation in cross-sectional stock comovement and impact of index-based strategies

Journal of financial markets (Amsterdam, Netherlands), 2024-03, Vol.68, p.100894, Article 100894

2024

Link zum Volltext

Verfügbarkeit prüfen

Analysis of adverse drug reactions of Osimertinib in the 2nd‐line treatment of EGFR mutant advanced nonsmall cell lung cancer

Precision medical sciences, 2022-06, Vol.11 (2), p.69-81

2022

Link zum Volltext

Verfügbarkeit prüfen

Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)

Journal of the National Cancer Center, 2023-12, Vol.3 (4), p.256-265

2023

Link zum Volltext

Verfügbarkeit prüfen

Prolonged survival in advanced squamous cell lung carcinoma by rational and standardized treatment: A case report of long‐term survival in a patient with NSCLC

Precision medical sciences, 2021-03, Vol.10 (1), p.33-41

2021

Link zum Volltext

Verfügbarkeit prüfen

Anti-PD-1 antibody monotherapy or anti-PD-1 antibody combination with chemotherapy treated non-small cell lung cancer (NSCLC) patients with EGFR mutation: A retrospective analysis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21691-e21691

2020

Link zum Volltext

Verfügbarkeit prüfen

Study on synergistic catalytic degradation of wastewater containing polyacrylamide catalyzed by low-temperature plasma-H2O2

Environmental science and pollution research international, 2023-11, Vol.30 (52), p.112206-112221

2023

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Study on synergistic catalytic degradation of wastewater containing polyacrylamide catalyzed by low‑temperature plasma‑H2O2

Environmental science and pollution research international, 2023-12, Vol.30 (60), p.126232-126233

2023

Link zum Volltext

Verfügbarkeit prüfen

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2022-06, Vol.23 (6), p.739-747

2022

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner

International journal of nanomedicine, 2017-01, Vol.12, p.3721-3733

2017

Link zum Volltext

Verfügbarkeit prüfen

The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice

Biomedicine & pharmacotherapy, 2017-11, Vol.95, p.1082-1090

2017

Link zum Volltext

Verfügbarkeit prüfen

PhI(OAc) 2 /Pd(OAc) 2 promoted the formation of 8-hydroxyquinoline derivatives from benzoxazoles and alcohols

Organic & biomolecular chemistry, 2023-02, Vol.21 (6), p.1148-1152

2023

Link zum Volltext

Verfügbarkeit prüfen

Current and future biomarkers in gastric cancer

Biomedicine & pharmacotherapy, 2018-07, Vol.103, p.1688-1700

2018

Link zum Volltext

Verfügbarkeit prüfen

Design of an Adaptive Height Control System for Sugarcane Harvester Header

Agronomy (Basel), 2024-07, Vol.14 (8), p.1644

2024

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II study of TQ-B2450, a PD-L1 mAb, plus anlotinib in EGFR+ advanced NSCLC patients failed to prior EGFR TKI therapies

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21062-e21062

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 233

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(224)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(158)
Life Sciences & Biomedicine
(85)
Technology
(58)
Physical Sciences
(43)
Chemistry
(37)
Humans
(36)
Oncology
(36)
Engineering
(27)
Materials Science
(27)
Science & Technology - Other Topics
(23)
Lung Cancer
(22)
Materials Science, Multidisciplinary
(21)
Chemotherapy
(18)
Chemistry, Multidisciplinary
(15)
Chemistry, Physical
(14)
Engineering, Electrical & Electronic
(14)
Nanoscience & Nanotechnology
(14)
Cancer Therapies
(13)
Female
(13)
Male
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells

Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

n-3 Polyunsaturated Fatty Acids and Metabolic Syndrome Risk: A Meta-Analysis

Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication

Effects of n-3 fatty acid supplements on glycemic traits in Chinese type 2 diabetic patients: A double-blind randomized controlled trial

Immunotherapy for bilateral multiple ground glass opacities: An exploratory study for synchronous multiple primary lung cancer

Supercapacitor‐based coordinated synthetic inertia scheme for voltage source converter‐based HVDC integrated offshore wind farm

Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China

Improving the Lung Cancer Clinical Trial Development by Incorporating Competing Risk Factors

Intraday variation in cross-sectional stock comovement and impact of index-based strategies

Analysis of adverse drug reactions of Osimertinib in the 2nd‐line treatment of EGFR mutant advanced nonsmall cell lung cancer

A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China

Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)

Prolonged survival in advanced squamous cell lung carcinoma by rational and standardized treatment: A case report of long‐term survival in a patient with NSCLC

Anti-PD-1 antibody monotherapy or anti-PD-1 antibody combination with chemotherapy treated non-small cell lung cancer (NSCLC) patients with EGFR mutation: A retrospective analysis

Study on synergistic catalytic degradation of wastewater containing polyacrylamide catalyzed by low-temperature plasma-H2O2

Correction to: Study on synergistic catalytic degradation of wastewater containing polyacrylamide catalyzed by low‑temperature plasma‑H2O2

Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner

The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice

PhI(OAc) 2 /Pd(OAc) 2 promoted the formation of 8-hydroxyquinoline derivatives from benzoxazoles and alcohols

Current and future biomarkers in gastric cancer

Design of an Adaptive Height Control System for Sugarcane Harvester Header

A phase I/II study of TQ-B2450, a PD-L1 mAb, plus anlotinib in EGFR+ advanced NSCLC patients failed to prior EGFR TKI therapies

Suchergebnisse filtern